Reuters Pharma USA 2026
Mar 16, 2026 | MondayPhiladelphia, USA
Insights
We were at Reuters Pharma USA 2026, engaging with leaders across commercial, medical, and analytics teams on how the industry is evolving. Conversations focused on how organizations are moving from insight generation to real execution by better connecting data, analytics, and field strategy. It was a valuable opportunity to exchange perspectives, share our experience, and understand how leading teams are driving more consistent and measurable impact across commercial functions.
Representative
Ashish Agrawal
CEO, ProcDNA
Varsha Eluri
Partner, ProcDNA
Adyant Jha
Senior Engagement Lead, ProcDNA
Akanksha Nangia
Senior Engagement Lead, Analytics, ProcDNA
Key Takeaways from the Event
Execution-focused analytics in commercial pharma
Conversations focused on how organizations are moving beyond reporting to enable faster, more consistent decision making across commercial teams.
AI adoption in real-world use cases
Discussions highlighted how AI is being applied across forecasting, targeting, and engagement, with a clear focus on practical implementation and measurable outcomes.
Evolving HCP engagement strategies
Leaders shared how omnichannel approaches are becoming more precise, with better use of data to improve timing, personalization, and channel effectiveness.
Importance of connected data ecosystems
There was strong emphasis on integrating CRM, MDM, and analytics to create a unified view that supports better execution and cross functional alignment.
Want to Gain Insights from the Event? Reach out to us
